Finance

Lists
Q3 2026 earnings • released • EPS beat +10,34% • Revenue beat +3,74%
See results
USPH:NYSE
US Physical Therapy Inc
USD 97,20
+8,99%
(+8,02) 1D
USD 96,70
-0,51% (-0,50)
After hours
Closed: 5 Nov., 16:00:04 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for USPH...
Open
USD 94,00
High
USD 100,98
Low
USD 94,00
Mkt. cap
1,45 mjd
Avg. vol.
175,62 k
Volume
309,31 k
Dividend
1,89%
Quarterly dividend
USD 0,46
Ex-dividend date
21 Aug. 2026
P/E ratio
553,09
52-wk high
USD 100,98
52-wk low
USD 58,19
EPS
USD 0,18
Beta
1,16
Shares outstanding
14,92 m
No. of employees
6 k
Open
USD 94,00
High
USD 100,98
Low
USD 94,00
Mkt. cap
1,45 mjd
Avg. vol.
175,62 k
Volume
309,31 k
Dividend
1,89%
Quarterly dividend
USD 0,46
Ex-dividend date
21 Aug. 2026
P/E ratio
553,09
52-wk high
USD 100,98
52-wk low
USD 58,19
EPS
USD 0,18
Beta
1,16
Shares outstanding
14,92 m
No. of employees
6 k
News stories
From web sources and news partners
About US Physical Therapy Inc
CEO-
Employees6,37 k
Founded1990
HeadquartersHouston, Texas, Verenigde State van Amerika
SectorHealth Care
IndustryHealth care provider
Websiteusph.com
Analyst ratings
Based on 4 analysts giving stock ratings to USPH in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for USPH in the last 3 months.
Highest
Current USD 97,20
USD 98,00 (+0,82%)
Average
USD 96,50 (-0,72%)
Lowest
USD 95,00 (-2,26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joanna Gajuk
Bank of America Securities
Buy
Maintained
-
-
11/05/2026
Michael Petusky
Barrington
Buy
Maintained
USD 98,00
+0,8%
10/23/2026
Benjamin Rossi
J.P. Morgan
Buy
Maintained
USD 95,00
-2,3%
09/11/2026
Jared Haase
William Blair
Hold
Reiterated
-
-
08/14/2026
Constantine Davides
Citizens JMP
Buy
Maintained
USD 98,00
+0,8%
05/08/2026
Jack Slevin
Jefferies
Buy
Reiterated
USD 102,00
+4,9%
03/09/2026
Last report
05 Nov. 2026
Fiscal period
Q3 2026
USD 0,80 / USD 0,73
+10,34%beat
Revenue / Est. (USD)
222,56 m / 214,54 m
+3,74%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
195,06 m
201,00 m
196,28 m
211,94 m
Cost of goods sold
152,73 m
156,58 m
157,94 m
164,37 m
Cost of revenue
152,73 m
156,58 m
157,94 m
164,37 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,41 m
18,12 m
18,27 m
18,37 m
Operating expense
22,91 m
22,41 m
23,93 m
23,99 m
Total operating expenses
175,64 m
178,99 m
181,87 m
188,36 m
Operating income
19,42 m
22,01 m
14,41 m
23,58 m
Other non operating income
-441,00 k
198,00 k
494,00 k
7,00 k
EBT including unusual items
22,88 m
14,96 m
10,56 m
19,05 m
EBT excluding unusual items
16,96 m
20,20 m
12,49 m
20,81 m
Income tax expense
5,23 m
5,78 m
2,41 m
4,16 m
Effective tax rate
22,88%
38,66%
22,79%
21,81%
Other operating expenses
-
-
-
-
Net income
13,14 m
4,15 m
5,04 m
9,90 m
Net profit margin
6,74%
2,07%
2,57%
4,67%
Earnings per share
0,66
0,67
0,46
0,75
Interest and investment income
33,00 k
20,00 k
16,00 k
29,00 k
Interest expense
-2,41 m
-2,35 m
-2,79 m
-3,21 m
Net interest expenses
-2,38 m
-2,33 m
-2,78 m
-3,18 m
Depreciation and amortization charges
5,50 m
4,28 m
5,66 m
5,62 m
EBITDA
25,25 m
26,64 m
20,41 m
29,52 m
Gain or loss from assets sale
-18,00 k
-37,00 k
99,00 k
203,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme